IDO Inhibitor Study for Relapsed or Refractory Solid Tumors
Status: TERMINATED
Study type: INTERVENTIONAL
Conditions: Breast Cancer|Lung Cancer|Melanoma|Pancreatic Cancer|Solid Tumors
Interventions: DRUG: 1-methyl-D-tryptophan
Sponsor: NewLink Genetics Corporation